Loading clinical trials...
Loading clinical trials...
The aim of this study is to assess the safety and efficacy of HANBIO BarriGel to prevent thyroidectomy postoperative adhesions
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
HAN Biomedical Inc
NCT07081997 · Hypoparathyroidism, Endocrine System Diseases, and more
NCT07462195 · Thyroid Diseases
NCT04785443 · Thyroid Diseases
NCT07416591 · Infertile Women With Pelvic Adhesions
NCT07382973 · Thyroid Diseases, Wound Healing, and more
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City
Kaohsiung Veterans General Hospital
Kaohsiung City
Keelung Chang Gung Memorial Hospital
Keelung
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions